PAS
Park Avenue Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,750
| Closed | -$226K | – | 1389 |
|
|
2024
Q2 | $226K | Sell |
2,750
-1,870
| -40% | -$154K | ﹤0.01% | 1275 |
|
|
2024
Q1 | $403K | Sell |
4,620
-1,578
| -25% | -$138K | 0.01% | 1056 |
|
|
2023
Q4 | $598K | Buy |
6,198
+1,117
| +22% | +$108K | 0.01% | 842 |
|
|
2023
Q3 | $450K | Buy |
+5,081
| New | +$450K | 0.01% | 885 |
|
|
2023
Q1 | – | Sell |
-2,560
| Closed | -$265K | – | 753 |
|
|
2022
Q4 | $265K | Sell |
2,560
-11
| -0.4% | -$1.14K | ﹤0.01% | 1026 |
|
|
2022
Q3 | $218K | Buy |
+2,571
| New | +$218K | ﹤0.01% | 1034 |
|
|
2020
Q3 | – | Sell |
-1,694
| Closed | -$209K | – | 742 |
|
|
2020
Q2 | $209K | Buy |
+1,694
| New | +$209K | 0.01% | 629 |
|